Previous 10 | Next 10 |
MARIETTA, Ga, June 16, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced that Timothy R. Wright, Chief Executive Of...
Proposed Mechanism Suggests Potential Path to Improve Outcomes in Clinical Applications where the Regulation of Excessive Fibrosis Can Promote a Normal Healing Response Complex Nature of MIMEDX dHACM May Prove Useful in a Multitude of Applications Where Normal Healing Is Impaire...
Mimedx Group (MDXG) announces successful regulatory approval by the Japanese Ministry of Health, Labour and Welfare ((JMHLW)) to market Epifix in Japan. Epifix - a bioabsorbable, human amniotic membrane allograft, is applied to affected areas for wound healing.The product uses proprietary met...
Availability of EPIFIX Allografts Expected Early 2022 Approval Makes it Possible to Bring EPIFIX’s Healing Properties to as Many as 100,000 New Patients Annually MARIETTA, Ga., June 08, 2021 (GLOBE NEWSWIRE) -- MIMEDX Group, Inc. (Nasdaq: MDXG) (“MIMEDX...
4 Penny Stocks That Hit It Big In the Past Year As penny stocks investors, we love to see a company go from the under $5 mark to well beyond that number. While this is a rare occurrence, it does happen. And when it does, investors take note. Most of the time, those trading penny s...
Big hits from Bitcoin drops balanced out by a timely Virgin Galactic purchase means that May was anything but boring. A new trade is set up for the beginning of June as I build a smaller position into an overly-large one for a key upcoming catalyst. A portfolio built for individua...
MARIETTA, Ga., May 27, 2021 (GLOBE NEWSWIRE) -- MIMEDX Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced that Timothy R. Wright, Chief Executive Officer...
Deadline to Pre-Register Extended to May 26, 2021 at 10:00 a.m. Eastern Pre-Registration Required to Attend Annual Meeting Visit w ww.votemimedx.com for Instructions on How to Pre-Register MARIETTA, Ga., May 25, 2021 (GLOBE NEWSWIRE) -- MIMEDX G...
Vote FOR MIMEDX’s Experienced and Highly Qualified Directors and Governance Enhancement Proposals MARIETTA, Ga., May 12, 2021 (GLOBE NEWSWIRE) -- MIMEDX Group, Inc. (NASDAQ: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amnioti...
MiMedx Group (MDXG) has been issued a patent covering placental tissue composition for treating cardiac tissue damage.The company uses dehydrated amniotic tissue and placental-based tissue for wound and burn care, as well as surgical applications.MiMedx shares are up 0.5% to $9.51 i...
News, Short Squeeze, Breakout and More Instantly...
Study adds to the Company’s growing body of evidence and expands the understanding of the regulatory capabilities of its DHACM and LHACM allografts on the fibrotic process Marks MIMEDX’s first publication in the 5 th most-cited journal in the world MARIET...
Rick Barry appointed Executive Chairman of the Board Remi Barbier resigns as President and CEO and from the Board of Directors Cassava initiates search for a new CEO AUSTIN, Texas, July 17, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) today announced that the Boa...
MARIETTA, Ga., July 17, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the second quarter ended June 30, 2024 after the market close on Wednesday, July 3...